Copyright Reports & Markets. All rights reserved.

Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales Market Report 2019 by Manufacturer, Region, Type and Application

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Definition and Specification
    • 1.2 Report Overview
      • 1.2.1 Manufacturers Overview
      • 1.2.2 Regions Overview
      • 1.2.3 Type Overview
      • 1.2.4 Application Overview
    • 1.3 Industrial Chain
      • 1.3.1 Castration-Resistant Prostate Cancer (CRPC) Treatment Overall Industrial Chain
      • 1.3.2 Upstream
      • 1.3.3 Downstream
    • 1.4 Industry Situation
      • 1.4.1 Industrial Policy
      • 1.4.2 Product Preference
      • 1.4.3 Economic/Political Environment
    • 1.5 SWOT Analysis

    2 Market Analysis by Types

    • 2.1 Overall Market Performance(Volume)
      • 2.1.1 Chemotherapy
      • 2.1.2 Hormonal Therapy
      • 2.1.3 Immunotherapy
      • 2.1.4 Radiotherapy
    • 2.2 Overall Market Performance(Value)
      • 2.2.1 Chemotherapy
      • 2.2.2 Hormonal Therapy
      • 2.2.3 Immunotherapy
      • 2.2.4 Radiotherapy

    3 Product Application Market

    • 3.1 Overall Market Performance (Volume)
      • 3.1.1 Hospitals
      • 3.1.2 Clinics
      • 3.1.3 Others

    4 Manufacturers Profiles/Analysis

    • 4.1 Astellas Pharma
      • 4.1.1 Astellas Pharma Profiles
      • 4.1.2 Astellas Pharma Product Information
      • 4.1.3 Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.1.4 Astellas Pharma Castration-Resistant Prostate Cancer (CRPC) Treatment Business Development and Market Status
    • 4.2 Johnson & Johnson
      • 4.2.1 Johnson & Johnson Profiles
      • 4.2.2 Johnson & Johnson Product Information
      • 4.2.3 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.2.4 Johnson & Johnson Castration-Resistant Prostate Cancer (CRPC) Treatment Business Development and Market Status
    • 4.3 Sanofi
      • 4.3.1 Sanofi Profiles
      • 4.3.2 Sanofi Product Information
      • 4.3.3 Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.3.4 Sanofi Castration-Resistant Prostate Cancer (CRPC) Treatment Business Development and Market Status
    • 4.4 Valeant
      • 4.4.1 Valeant Profiles
      • 4.4.2 Valeant Product Information
      • 4.4.3 Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.4.4 Valeant Castration-Resistant Prostate Cancer (CRPC) Treatment Business Development and Market Status
    • 4.5 Dendreon
      • 4.5.1 Dendreon Profiles
      • 4.5.2 Dendreon Product Information
      • 4.5.3 Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.5.4 Dendreon Castration-Resistant Prostate Cancer (CRPC) Treatment Business Development and Market Status
    • 4.6 Bayer
      • 4.6.1 Bayer Profiles
      • 4.6.2 Bayer Product Information
      • 4.6.3 Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.6.4 Bayer Castration-Resistant Prostate Cancer (CRPC) Treatment Business Development and Market Status
    • 4.7 ...
      • 4.7.1 ... Profiles
      • 4.7.2 ... Product Information
      • 4.7.3 ... Castration-Resistant Prostate Cancer (CRPC) Treatment Business Performance
      • 4.7.4 ... Castration-Resistant Prostate Cancer (CRPC) Treatment Business Development and Market Status

    5 Market Performance for Manufacturers

    • 5.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Market Share by Manufacturers 2014-2019
    • 5.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Market Share by Manufacturers 2014-2019
    • 5.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
    • 5.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
    • 5.5 Market Concentration

    6 Regions Market Performance for Manufacturers

    • 6.1 China Market Performance for Manufacturers
      • 6.1.1 China Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.1.2 China Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.1.3 China Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
      • 6.1.4 China Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
      • 6.1.5 Market Concentration
    • 6.2 USA Market Performance for Manufacturers
      • 6.2.1 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.2.2 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.2.3 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
      • 6.2.4 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
      • 6.2.5 Market Concentration
    • 6.3 Europe Market Performance for Manufacturers
      • 6.3.1 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.3.2 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.3.3 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
      • 6.3.4 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
      • 6.3.5 Market Concentration
    • 6.4 Japan Market Performance for Manufacturers
      • 6.4.1 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.4.2 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.4.3 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
      • 6.4.4 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
      • 6.4.5 Market Concentration
    • 6.5 Korea Market Performance for Manufacturers
      • 6.5.1 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.5.2 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.5.3 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
      • 6.5.4 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
      • 6.5.5 Market Concentration
    • 6.6 India Market Performance for Manufacturers
      • 6.6.1 India Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.6.2 India Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.6.3 India Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
      • 6.6.4 India Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
      • 6.6.5 Market Concentration
    • 6.7 Southeast Asia Market Performance for Manufacturers
      • 6.7.1 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.7.2 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.7.3 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
      • 6.7.4 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
      • 6.7.5 Market Concentration
    • 6.8 South America Market Performance for Manufacturers
      • 6.8.1 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Share of Manufacturers 2014-2019
      • 6.8.2 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Share of Manufacturers 2014-2019
      • 6.8.3 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) of Manufacturers 2014-2019
      • 6.8.4 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin of Manufacturers 2014-2019
      • 6.8.5 Market Concentration

    7 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Market Performance (Sales Point)

    • 7.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Market Share by Regions 2014-2019
    • 7.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Revenue (M USD) and Market Share by Regions 2014-2019
    • 7.3 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) by Regions 2014-2019
    • 7.4 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Margin by Regions 2014-2019

    8 Development Trend for Regions (Sales Point)

    • 8.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.2 China Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.3 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate2014-2019
    • 8.4 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.5 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.6 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.7 India Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.8 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate 2014-2019
    • 8.8 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Sales and Growth, Sales Value and Growth Rate 2014-2019

    9 Upstream Source, Technology and Cost

    • 9.1 Upstream Source
    • 9.2 Technology
    • 9.3 Cost

    10 Channel Analysis

    • 10.1 Market Channel
    • 10.2 Distributors

    11 Consumer Analysis

    • 11.1 Hospitals Industry
    • 11.2 Clinics Industry
    • 11.3 Others Industry

    12 Market Forecast 2020-2025

    • 12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2020-2025
      • 12.1.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Market Share by Regions 2020-2025
      • 12.1.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units) and Growth Rate 2020-2025
      • 12.1.3 China Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.4 USA Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.5 Europe Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.6 Japan Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.7 Korea Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.8 India Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.9 Southeast Asia Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
      • 12.1.10 South America Castration-Resistant Prostate Cancer (CRPC) Treatment Sales (K Units), Revenue (M USD) and Growth Rate 2020-2025
    • 12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2020-2025
      • 12.2.1 Overall Market Performance
      • 12.2.2 Chemotherapy
      • 12.2.3 Hormonal Therapy
      • 12.2.4 Immunotherapy
      • 12.2.5 Radiotherapy
    • 12.3 Sales (K Units) Forecast by Application 2020-2025
      • 12.3.1 Overall Market Performance
      • 12.3.2 Hospitals
      • 12.3.3 Clinics
      • 12.3.4 Others
    • 12.4 Price (USD/Unit) and Gross Profit
      • 12.4.1 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Price (USD/Unit) Trend 2020-2025
      • 12.4.2 Global Castration-Resistant Prostate Cancer (CRPC) Treatment Gross Profit Trend 2020-2025

    13 Conclusion

    Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of Castration-Resistant Prostate Cancer (CRPC) Treatment for these regions, from 2012 to 2023 (forecast), covering
    China
    USA
    Europe
    Japan
    Korea
    India
    Southeast Asia
    South America

    Global Castration-Resistant Prostate Cancer (CRPC) Treatment market competition by top manufacturers/players, with Castration-Resistant Prostate Cancer (CRPC) Treatment sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
    Astellas Pharma
    Johnson & Johnson
    Sanofi
    Valeant
    Dendreon
    Bayer
    ...
    ...
    On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Chemotherapy
    Hormonal Therapy
    Immunotherapy
    Radiotherapy
    On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Castration-Resistant Prostate Cancer (CRPC) Treatment for each application, including
    Hospitals
    Clinics
    Others

    If you have any special requirements, please let us know and we will offer you the report as you want.

    Buy now